
Lenalid 25 mg Capsule
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
What is Lenalid (Lenalidomide) Used For?
- Lenalid (Lenalidomide) is used for:
- Multiple Myeloma β In combination with dexamethasone for newly diagnosed and relapsed disease
- Myelodysplastic Syndromes (MDS) β Transfusion-dependent anemia with 5q deletion
- Mantle Cell Lymphoma β Relapsed or refractory after prior bortezomib therapy
- Follicular Lymphoma β With rituximab for relapsed/refractory disease
How Does Lenalid Work?
- Lenalid contains Lenalidomide, which:
- Is an immunomodulatory agent with multiple mechanisms of action
- Enhances immune cell function and induces apoptosis in malignant cells
- Inhibits angiogenesis and modifies the tumor microenvironment
How to Use Lenalid
Dosage: 25mg once daily on days 1-21 of 28-day cycles (cycle-based dosing)
Administration: Take orally at same time daily; swallow capsule whole
Precaution: REMS program required due to teratogenicity; mandatory pregnancy prevention; monitor blood counts; oncologist supervision mandatory
Side Effects of Lenalid
Common Side Effects: Neutropenia, thrombocytopenia, anemia, diarrhea, constipation, fatigue, muscle cramps
Serious Side Effects (seek medical help): Deep vein thrombosis, pulmonary embolism, severe infections, second primary malignancies, tumor lysis syndrome
Benefits
- Cereblon-binding IMiD β degrades IKZF1/IKZF3 transcription factors critical for myeloma cell survival
- Activates T-cells and NK cells to enhance anti-myeloma immune response
- Standard of care in combination with dexamethasone (Rd) for newly diagnosed and relapsed myeloma
- Significantly reduces transfusion dependence in MDS with 5q deletion
- Patients requiring Lenalidomide may find 5mg, 10mg, 15mg, and 25mg strengths available as Lenalid at Medionix Pharma
Warnings and Precautions
- REMS mandatory: teratogen causing severe birth defects β two forms of contraception and monthly pregnancy tests required for women of childbearing potential; men must use condoms
- VTE prophylaxis required: aspirin for standard risk; LMWH or warfarin for high-risk patients (prior clots, immobility, dexamethasone combination)
- Severe myelosuppression: CBC monitoring weekly for first 8 weeks then monthly β dose reductions for significant cytopenias
- Second primary malignancies reported with long-term use; weigh risk-benefit during extended maintenance
- Do not use Lenalidomide monotherapy in patients with HBV β increased risk of viral reactivation
- Tumor lysis syndrome possible in early treatment cycles β ensure adequate hydration and uric acid monitoring
Drug Interactions
- Dexamethasone: standard co-administration β enhances efficacy but increases VTE and infection risk
- Erythropoiesis-stimulating agents: increased VTE risk when combined with Lenalidomide β avoid or use with anticoagulation
- Digoxin: Lenalidomide may increase digoxin levels β monitor carefully
- Warfarin: increased INR reported β closer INR monitoring required during combination treatment
Storage Information
- Store below 25Β°C in original child-resistant packaging; protect from moisture
- Unused capsules must be returned to the pharmacy β do not dispose in household waste
- Capsules must not be opened, crushed, or broken β handle with care to avoid skin contact
Frequently Asked Questions
Q1: What is Lenalid 25mg (Lenalidomide) used for?
Lenalid 25mg is used to treat newly diagnosed and relapsed/refractory multiple myeloma (with dexamethasone), transfusion-dependent anemia in MDS with 5q deletion, and relapsed/refractory mantle cell and follicular lymphoma.
Q2: How does Lenalidomide work against myeloma?
Lenalidomide is an immunomodulatory drug (IMiD) that binds to cereblon, causing degradation of IKZF1 and IKZF3 transcription factors critical for myeloma cell survival. It also activates T-cells and NK cells against tumor cells and inhibits tumor angiogenesis.
Q3: What is the dosing cycle for Lenalid 25mg?
The standard dose is 25mg once daily on Days 1β21 of a 28-day cycle, always combined with dexamethasone. Cycles are repeated until progression or unacceptable toxicity. Dose reductions are made for adverse effects.
Q4: Why is Lenalidomide subject to a REMS program?
Lenalidomide is highly teratogenic β it causes life-threatening birth defects. The REMS (Risk Evaluation and Mitigation Strategy) program mandates two forms of contraception, monthly pregnancy testing for women, and prescription controls to prevent fetal exposure.
Q5: What are the most common side effects?
Common side effects include neutropenia (low white cells), thrombocytopenia (low platelets), anemia, diarrhea, constipation, fatigue, and muscle cramps. Blood count monitoring is mandatory.
Q6: What serious side effects require emergency care?
Seek immediate care for: DVT/pulmonary embolism (leg swelling, chest pain, shortness of breath), severe infections with fever, tumor lysis syndrome (sudden muscle pain, confusion, irregular heartbeat), or severe skin reactions.
Q7: What blood clot prevention is needed with Lenalidomide?
All patients require thromboprophylaxis β typically low-dose aspirin for standard-risk patients, and low molecular weight heparin or warfarin for high-risk patients. Risk factors include prior clots, immobility, and combination with dexamethasone.
Q8: Should Lenalid 25mg be taken with food?
It can be taken with or without food. Take at the same time each day. Swallow capsules whole β do not open, crush, or break them. If a capsule is opened, avoid skin or mucous membrane contact.
Q9: What blood tests are required during treatment?
Complete blood count (CBC) must be checked weekly for the first 8 weeks, then monthly. Kidney function and liver function tests are also monitored periodically throughout treatment.
Q10: Is Lenalidomide safe during pregnancy?
No. Lenalidomide is absolutely contraindicated in pregnancy. It is a potent teratogen that causes severe limb and other birth defects. Mandatory pregnancy prevention measures apply to all patients capable of pregnancy.
Q11: How should Lenalid capsules be stored?
Store at room temperature below 25Β°C, protected from moisture. Keep in the original child-resistant packaging. Dispose of unused capsules safely β they must not be discarded in household waste.
Q12: Is Lenalid available without a prescription?
No. Lenalidomide is only dispensed through authorized pharmacies under strict REMS controls. A valid prescription from an oncologist and REMS program enrollment are required.
Customer Reviews
Regional Cancer Institute
USA Β· 6 weeks ago
βUsed Medionix for supplementary oncology supply for over a year now. Reliable, consistent quality and timely delivery.β
Dr. Fatima Al-Rashid
UK Β· 3 months ago
βTrusted source for specialist oncology procurement. Products always arrive within expiry in manufacturer-sealed packaging.β
Northside Medical Center
Australia Β· 3 weeks ago
βRoutine oncology supply order. Medications arrived temperature-controlled and within the stated delivery window. Highly reliable.β
Regional Cancer Institute
USA Β· 6 weeks ago
βUsed Medionix for supplementary oncology supply for over a year now. Reliable, consistent quality and timely delivery.β
Dr. Fatima Al-Rashid
UK Β· 3 months ago
βTrusted source for specialist oncology procurement. Products always arrive within expiry in manufacturer-sealed packaging.β
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.






